Photocure ASA: Landmark Blue Light Cystoscopy with

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
539
Photocure ASA: Landmark Blue Light Cystoscopy with Cysview® study is published in the Journal of Urology

Oslo, Norway, December 8, 2017: Photocure ASA (Photocure, PHO: OSE), today announced that the official Journal of the American Urologic Association (AUA), the Journal of Urology, published the   BLFCC Efficacy  results from a Phase 3 trial investigating the efficacy of Blue Light Cystoscopy (BLC (TM) ) with Cysview ® for surveillance with a flexible cystoscope.  In 20.6 percent of patient's recurrence was seen only with BLC with Cysview and missed with WLC (p<0.0001). 

Out of the 304 patients in the study, 103 were referred to the Operating Room for suspicion of recurrent bladder cancer. Of these, 63 patients were confirmed as having malignant tumors.  Forty one percent of the patients with malignant tumors were confirmed as having CIS (Carcinoma in Situ), the most aggressive and difficult to detect and treat type of non-muscle invasive bladder cancer (NMIBC).  Importantly, 34% of these patients were detected only with BLC with Cysview (p<0.0001) but were missed with WLC.

"This study, which despite being carried out in centers with bladder cancer and BLC expertise, showed that blue light flexible cystoscopy significantly (p<0.0001) improves detection of patients with recurrent bladder cancer.  BLC detects lesions, including CIS that were missed with WLC alone.  The detection of additional tumors in the surveillance setting may have profound effects on progression rates through earlier diagnosis of high risk lesions which would have been otherwise missed with WLC.  The results of this study confirm the role for BLC in the management of intermediate and high risk bladder cancer patients," says J. Stephen Jones, MD, president of Cleveland Clinic Regional Hospitals and Family Health Centers .

 "This publication reports the data included in the supplemental NDA submitted to the FDA to get approval for the use of BLC with Cysview in the surveillance setting with flexible cystoscopy. We look forward to bringing this technology to bladder cancer patients and their health care providers for the follow-up of NMIBC in the office setting," said Kjetil Hestdal, M.D., Ph.D., President and CEO, Photocure ASA."

The study is a prospective, open, comparative within-patient controlled study of 304 patients with high risk of recurrence enrolled at 17 academic centers in the US.

About Bladder Cancer Bladder cancer is the fifth most commonly diagnosed cancer in the US and is the fourth most common cancer found in men in the US. 1,2,3  In 2016, it is estimated that 76,960 new cases of bladder cancer will occur along with 16,390 deaths due to bladder cancer.

Bladder cancer is one of the most expensive cancers to manage, accounting for approximately $3.7 billion in direct costs each year. 4,5 

Bladder cancer is classified into two types, non-muscle invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC), depending on the depth of invasion in the bladder wall. 2  NMIBC remains in the inner layer of cells lining the bladder. These cancers are the most common (70%) of all BC cases and include the subtypes Ta, carcinoma in situ (CIS) and T1 lesions. MIBC is when the cancer has grown into deeper layers of the bladder wall. These cancers, including subtypes T2, T3 and T4, are more likely to spread and are harder to treat. 2

About Hexvix ® /Cysview ® Hexvix ® /Cysview ® is a drug that is selectively taken up by cancer cells in the bladder making them glow bright pink during Blue Light Cystoscopy (BLC TM ).  BLC TM with Hexvix ® /Cysview ® improves the detection of tumors and leads to more complete resection, less residual tumors and better management decisions.

Cysview® is the tradename in the US and Canada, Hexvix® is the tradename in all other markets. Photocure is commercializing Hexvix®/Cysview® directly in the US and the Nordic region, and has strategic partnerships for the commercialization of Hexvix®/Cysview® in Europe, Canada, Australia and New Zealand. Please refer to https://www.photocure.com/Partnering-with-Pho...r-partners for further information on our commercial partners.

About Photocure Photocure, headquartered in Oslo Norway, is a specialty pharmaceutical company focusing on urology. Based on its unique proprietary Photocure Technology® platform, Photocure is committed to developing and commercializing highly selective and minimally invasive solutions to improve health outcomes for patients worldwide. The company is listed on the Oslo Stock Exchange (OSE: PHO). More information about Photocure is available at www.photocure.com , www.hexvix.com , www.cysview.com

Company contacts: Kjetil Hestdal, President and CEO Tel: +47 913 19 535 Email: kh@photcure.no

Erik Dahl, Chief Financial Officer Tel: +47 450 55 000 Email: ed@photocure.no  

References: 1. SEER Cancer Statistics Factsheets: Bladder Cancer. National Cancer Institute. Bethesda,  MD. http://seer.cancer.gov/statfacts/html/urinb.html . Accessed April 2016. 2. Bladder Cancer. American Cancer Society.  http://www.cancer.org/acs/groups/cid/document...85-pdf.pdf . Accessed April 2016. 3. Hall M, Chang S, Dalbagni G et al. Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update. J Urol. 2007;178(6):2314-2330. 4. Avritscher EB et al., Clinical model of lifetime cost of treating bladder cancer and associated complications. Urology. 2006; 68:549-553. 5. Botteman et al. Clinical model of lifetime costs of treating bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics. 2003; 21:315-1330.

All trademarks mentioned in this release are protected by law and are registered trademarks of Photocure ASA

This press release may contain product details and information which are not valid, or a product is not accessible, in your country. Please be aware that Photocure does not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Adecco Finds AI Value Depends on Better Work Redesign

Updated Category News Views 0

A shiny AI license is not a productivity strategy, and Adecco's latest workforce survey puts some hard numbers behind that irritation. The company surveyed 40,500 workers in 36 countries for its seventh Global Workforce of the Future report, released November 19, 2026. Its central finding is disarmingly sensible: AI produces more when companies rebuild the work around it...

Continue Reading
Nightguards and TMJ Appliances Require Different Calls

Updated Category News Views 126

Two clear plastic devices can invite a costly wrong turn. Dr. Terrance O’Keefe’s explanation, published Nov. 18, 2026, draws a line that patients too often blur: a nightguard protects teeth from grinding, while a TMJ appliance is meant to address joint and muscle strain tied to temporomandibular disorders. They may look alike sitting in a case. Their jobs are not...

Continue Reading
MIND Takes Its Copilot Security Bet Across Microsoft 365

Updated Category News Views 81

Copilot’s promise gets a lot less charming the minute confidential files start wandering around unchecked. That is the knot MIND is trying to untie with its expanded, generally available integrations across Microsoft Copilot, Microsoft 365, Purview, Teams, SharePoint, OneDrive, Edge and Exchange. The Seattle data-loss-prevention company announced the collaboration on...

Continue Reading
HiTHIUM's 8-Hour Storage Pitch Faces Real Grid Tests

Updated Category News Views 89

Eight hours of stored electricity is where the sales brochure meets the ugly parts of the grid. HiTHIUM arrived at RE+ 2026 in Las Vegas, held November 17 through 19, with a broad storage pitch: systems ranging from two to eight hours, lithium-ion and sodium-ion chemistry, plus the software and validation work needed to make a battery plant behave when the local grid gets...

Continue Reading
LevelTen Takes Its Clean-Power Market Model to India

Updated Category News Views 61

India's power market is not a tidy spreadsheet, thankfully. It is a vast, fast-growing grid where data centres, factories and climate exposure are all colliding with a generation mix still dominated by coal. That is why LevelTen Energy's move into Asia-Pacific deserves more than the usual clean-tech applause line. Beginning with a 500 MW clean-energy request for proposals...

Continue Reading
Travelzoo Turns Thanksgiving Delays Into Member Value

Updated Category News Views 95

Airport gridlock is a miserable place to make a membership pitch, yet Travelzoo has found a pretty shrewd angle for it. On November 18, the company said nearly 20 million travelers will move through airports during the upcoming Thanksgiving holiday, when cancellations and delays can turn an ordinary trip into a long, fluorescent-lit slog. Its offer: qualifying Club...

Continue Reading
Tactical Tomahawk Motor Deal Puts Propulsion in Focus

Updated Category News Views 288

A missile program lives or dies on unglamorous hardware, and solid rocket motors are about as unglamorous as it gets until somebody cannot build enough of them. Raytheon has awarded Ursa Major and Avio USA a joint contract to develop solid rocket motors for the U.S. Navy’s Tactical Tomahawk missile program. That is the whole headline, and it matters more than the thin...

Continue Reading
Thanksgiving Dog Safety Is a Pet Care Reality Check

Updated Category News Views 94

A crowded Thanksgiving kitchen can turn a well-behaved dog into a scavenger with lousy odds. Camp Bow Wow’s holiday guidance is not pretending the meal itself is the problem; the trouble is that a house full of distracted people, rich food and unsecured trash creates a pile of easy mistakes. For pet owners, that is a fair reminder. For anybody watching the pet-care...

Continue Reading
COPD Support Program Targets a Costly Care Gap Today

Updated Category News Views 153

Breathing trouble gets shrugged off far too easily, and that casual mistake has consequences. World COPD Day puts chronic obstructive pulmonary disease back in view, with the American Lung Association emphasizing a free Lung Health Navigator program for people living with COPD, their caregivers and families. This is not flashy medicine or a miracle-cure pitch. It is...

Continue Reading
LG Channels UAE Push Tests the Free Streaming Model

Updated Category News Views 137

A television's idle screen is turning into contested real estate in the UAE. LG Channels is adding programming from Rakuten TV, Stingray and Red Bull TV to its free, ad-supported service, and that matters for more than somebody hunting a movie after dinner. This is a practical push to make webOS-powered screens more useful, more frequently used and, eventually, more...

Continue Reading
on>

Top 5 Most Recently Viewed Articles

Exploring the Trading Landscape for Bitdeer Technologies

Updated Category News Views 99

Whales Are Bullish on Bitdeer Technologies Large investors, often referred to as whales, have shown a strong bullish sentiment towards Bitdeer Technologies. Recent observations from the options trading history reveal a total of eight significant trades in this period. Examining the nature of these trades indicates that approximately 62% were made with optimistic outlooks,...

Continue Reading
Successful Rafi's Amigos Golf Outing Raises Funds for JROTC

Updated Category News Views 188

Successful Fundraising at Rafi's Amigos Golf Outing On a recent day dedicated to supporting local youth, the Rafi's Amigos Golf Outing took place at Beavercreek Golf Club. Despite early rain, the weather brightened, allowing golfers and supporters to enjoy a seamless day on the course. With 116 participants, this year's event was recognized as a remarkable achievement,...

Continue Reading
Trinity Biotech Launches Innovative CGM Technology in India

Updated Category News Views 138

Trinity Biotech Prepares for CGM Launch in India Trinity Biotech plc (NASDAQ:TRIB), based in Dublin, is ready to make a notable stride in diabetes management with the launch of its advanced Continuous Glucose Monitoring (CGM) technology in India. The company has revealed plans for a crucial in-country study aimed at collecting feedback from diabetes patients and...

Continue Reading
Significant Market Growth for Fiberglass Fabrics Expected Soon

Updated Category News Views 259

Fiberglass Fabrics Market Growth Forecast A new market report reveals that the global fiberglass fabrics market is poised for substantial growth, projected to reach an increase of USD 2.83 billion between 2024 and 2028. This impressive expansion is expected to occur at a compound annual growth rate (CAGR) of 7.5% over the forecast period. The driving forces behind this...

Continue Reading
Earnings Insights for Hess Midstream: Key Metrics to Consider

Updated Category News Views 206

Anticipating Hess Midstream's Earnings Results Hess Midstream (NYSE:HESM) is gearing up to release its quarterly earnings report soon, poised to share vital insights that could impact investor sentiment. As the anticipation builds, understanding what to expect is crucial for current and prospective investors alike. Projected Earnings and Market Expectations Analysts are...

Continue Reading